Prot #ACE-ST-003: A Phase 2 Proof-of-Concept Study of ACP-196 Alone and in Combination with Pembrolizumab in Subjects with Advanced or Metastatic Pancreatic Cancer

Project: Research project

StatusFinished
Effective start/end date6/26/156/26/18

Funding

  • PRA Health Sciences (Prot #ACE-ST-003)
  • Acerta Pharma, LLC (Prot #ACE-ST-003)